PolyMedix Announces Positive Phase I Clinical Data With PMX-30063 Novel Antibiotic Drug Candidate

PolyMedix, Inc. , an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, has successfully completed its first-in-man Phase I clinical safety study with the novel antibiotic drug candidate PMX-30063.

More: continued here

Filed under: Biology on December 11th, 2008

Comments are closed.

« Connecticut Advocacy Group Unveils ‘Ambitious’ State Health Care Overhaul Proposal Prolonged Overall Survival For Patients With Acute Myeloid Leukemia Demonstrated By Data »

Get Rx Pharmacy - : Get Rx Pharmacy
Pills 2 Me - Order RX Pills for You: Just select the medicines you need, fill in our medical questionnaire, and submit your order.
RX Pills Store - Buy Drugs: RX pills sotre
Soma Drugs - Soma Pills: Soma is a muscle relaxant used to relieve the pain and stiffness of muscle.
Tramadol Tabs - Tramadol Tabs: Tramadol tablets
Discount prescripts - : Discount prescripts
Medicine Value - Medicine Value: Value the medicine advice
Online rx pharma - : Online rx pharma
Latest News...